Literature DB >> 24780824

Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease.

Atami Sagna1, Joseph J Gallo2, Gregory M Pontone3.   

Abstract

Depression and anxiety disorders have a substantial impact on the quality of life, the functioning and mortality of older adults with Parkinson's disease (PD). The purpose of this systematic review was to examine the factors associated with the prevalence of depression and anxiety disorders among individuals with PD aged 60 years and older. Following a literature search in PubMed, PsycINFO, CINAHL, and EMBASE, 5 articles met the inclusion criteria (adults aged 60 years and older, individuals with PD, and with depression and anxiety disorders, and English-language peer reviewed articles) and were included in this review. These studies were conducted in the U.S (n = 3), in Italy (n = 1) and the U.K (n = 1). Findings indicated that autonomic symptoms, motor fluctuations, severity and frequency of symptoms, staging of the disease, and PD onset and duration were associated with the prevalence of depression and anxiety disorders among older adults suffering from PD. Despite the limited number of studies included in the review, depression and anxiety disorders are often unrecognized and untreated and the comorbidity greatly exacerbates PD symptoms. The identification of factors associated with the development of depression and anxiety disorders could help in designing preventive interventions that would decrease the risk and burden of depression and anxiety disorders among older adults with PD.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety disorders; Depression; Factors; Older adults; Parkinson's disease; Systematic review

Mesh:

Year:  2014        PMID: 24780824      PMCID: PMC4648277          DOI: 10.1016/j.parkreldis.2014.03.020

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  33 in total

1.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne A Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

2.  Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study.

Authors:  Albert F G Leentjens; Kathy Dujardin; Laura Marsh; Pablo Martinez-Martin; Irene H Richard; Sergio E Starkstein
Journal:  Mov Disord       Date:  2011-02-10       Impact factor: 10.338

Review 3.  Assessment methods and factors associated with depression in Parkinson's disease.

Authors:  Nadeeka N Dissanayaka; John D O'Sullivan; Peter A Silburn; George D Mellick
Journal:  J Neurol Sci       Date:  2011-07-20       Impact factor: 3.181

4.  Anxiety, depression, and quality of life in Parkinson's disease.

Authors:  Rosa Quelhas; Manuela Costa
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

5.  Anxiety and depression severity are related to right but not left onset Parkinson's disease duration.

Authors:  Paul S Foster; Valeria Drago; Gregory P Crucian; William K Sullivan; Robert D Rhodes; Brian V Shenal; Barry Skoblar; Frank M Skidmore; Kenneth M Heilman
Journal:  J Neurol Sci       Date:  2011-03-21       Impact factor: 3.181

6.  Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.

Authors:  Laurence Nègre-Pagès; Hélène Grandjean; Maryse Lapeyre-Mestre; Jean Louis Montastruc; Annie Fourrier; Jean Pierre Lépine; Oliver Rascol
Journal:  Mov Disord       Date:  2010-01-30       Impact factor: 10.338

7.  Parkinson's disease and anxiety: comorbidity with depression.

Authors:  M A Menza; D E Robertson-Hoffman; A S Bonapace
Journal:  Biol Psychiatry       Date:  1993-10-01       Impact factor: 13.382

8.  Autonomic failure, depression and anxiety in Parkinson's disease.

Authors:  G E Berrios; C Campbell; B E Politynska
Journal:  Br J Psychiatry       Date:  1995-06       Impact factor: 9.319

9.  Risk of Parkinson disease after depression: a nationwide population-based study.

Authors:  Cheng-Che Shen; Shih-Jen Tsai; Chin-Lin Perng; Benjamin Ing-Tiau Kuo; Albert C Yang
Journal:  Neurology       Date:  2013-10-02       Impact factor: 9.910

10.  Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression.

Authors:  Salah U Qureshi; Amber B Amspoker; Jessica S Calleo; Mark E Kunik; Laura Marsh
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-11-29       Impact factor: 2.680

View more
  32 in total

1.  Collective rehabilitation training conductive to improve psychotherapy of college students with anxiety disorder.

Authors:  Wen-Li Yang; Feng Zhai; Yan-Min Gao; Qing-Hua Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  A practical approach to detection and treatment of depression in Parkinson disease and dementia.

Authors:  Zahra Goodarzi; Zahinoor Ismail
Journal:  Neurol Clin Pract       Date:  2017-04

3.  Neuropsychiatric characteristics of GBA-associated Parkinson disease.

Authors:  Matthew Swan; Nancy Doan; Robert A Ortega; Matthew Barrett; William Nichols; Laurie Ozelius; Jeannie Soto-Valencia; Sarah Boschung; Andres Deik; Harini Sarva; Jose Cabassa; Brooke Johannes; Deborah Raymond; Karen Marder; Nir Giladi; Joan Miravite; William Severt; Rivka Sachdev; Vicki Shanker; Susan Bressman; Rachel Saunders-Pullman
Journal:  J Neurol Sci       Date:  2016-08-30       Impact factor: 3.181

4.  Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration.

Authors:  Durga Praveen Meka; Anne Kathrin Müller-Rischart; Prakash Nidadavolu; Behnam Mohammadi; Elisa Motori; Srinivas Kumar Ponna; Helia Aboutalebi; Mahmoud Bassal; Anil Annamneedi; Barbara Finckh; Margit Miesbauer; Natalie Rotermund; Christian Lohr; Jörg Tatzelt; Konstanze F Winklhofer; Edgar R Kramer
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

5.  Motion and emotion: anxiety-axial connections in Parkinson's disease.

Authors:  Rastislav Šumec; Irena Rektorová; Robert Jech; Kateřina Menšíková; Jan Roth; Evžen Růžička; Dana Sochorová; Ladislav Dušek; Petr Kaňovský; Ivan Rektor; Tomáš Pavlík; Pavel Filip; Martin Bareš
Journal:  J Neural Transm (Vienna)       Date:  2016-11-23       Impact factor: 3.575

Review 6.  Effects of music and music therapy on mood in neurological patients.

Authors:  Alfredo Raglio; Lapo Attardo; Giulia Gontero; Silvia Rollino; Elisabetta Groppo; Enrico Granieri
Journal:  World J Psychiatry       Date:  2015-03-22

7.  Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial.

Authors:  Jojo Y Y Kwok; Jackie C Y Kwan; M Auyeung; Vincent C T Mok; Claire K Y Lau; K C Choi; Helen Y L Chan
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

8.  Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease.

Authors:  Davide L Vetrano; Maria S Pisciotta; Maria R Lo Monaco; Graziano Onder; Alice Laudisio; Vincenzo Brandi; Domenico La Carpia; Mauro Guglielmo; Antonio Nacchia; Domenico Fusco; Diego Ricciardi; Anna R Bentivoglio; Roberto Bernabei; Giuseppe Zuccalà
Journal:  J Neurol       Date:  2015-09-04       Impact factor: 4.849

9.  Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease.

Authors:  Nadeeka N W Dissanayaka; Elizabeth White; John D O'Sullivan; Rodney Marsh; Peter A Silburn; David A Copland; George D Mellick; Gerard J Byrne
Journal:  Mov Disord Clin Pract       Date:  2015-04-06

10.  Correlations between abnormal iron metabolism and non-motor symptoms in Parkinson's disease.

Authors:  Wu Xu; Yan Zhi; Yongsheng Yuan; Bingfeng Zhang; Yuting Shen; Hui Zhang; Kezhong Zhang; Yun Xu
Journal:  J Neural Transm (Vienna)       Date:  2018-05-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.